IP Library Granted Patent US 9,763,909
Granted Patent B2
US 9,763,909 · App. 15/363,384 · Granted Sep 19, 2017

Methods for treating inflammation and pain

Inventors: Joseph P. St. Laurent (Lakeville, MA); Gerald S. Jones (Norwood, MA); David M. Bresse (Middleboro, MA); George M. Shopp, Jr. (Boulder, CO)
Assignee: Olatec Therapeutics LLC
A61K31/275A61K9/0053A61K31/485
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,763,909
App. No.
15/363,384
Granted
Sep 19, 2017
Kind
B2
Abstract

The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an ω-(methanesulfonyl)alkenylnitrile compound, or a pharmaceutically acceptable salt thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering an ω-(methanesulfonyl)alkenylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. The present invention is further directed to a method for potentiating the analgesic effects of morphine, by administering an effective amount of 3-(methylsulfonyl)acrylonitrile to a subject who is being treated with morphine and is suffering from pain. Oral and topical administration are preferred.

Claims (7)

1. A method for treating pain, comprising:

administering to the subject suffering from pain an effective amount of morphine and an effective amount of 3-(methylsulfonyl)acrylonitrile.

2. The method according to claim 1 , wherein said pain is nociceptive pain.

3. A method for potentiating the analgesic effects of morphine, comprising:

administering an effective amount of 3-(methylsulfonyl)acrylonitrile to a subject who is being treated with morphine and is suffering from pain.

4. The method according to claim 3 , wherein said pain is nociceptive pain.

5. The method according to claim 3 , wherein said administering is by oral administration.

Assignments (2)
CHANGE OF NAME Recorded Nov 7, 2023
From: OLATEC THERAPEUTICS LLC
To: OLATEC THERAPEUTICS, INC.
Reel/Frame 065489/0809 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2016
From: ST. LAURENT, JOSEPH P.; JONES, GERALD S.; BRESSE, DAVID M.; SHOPP, GEORGE M.
To: OLATEC THERAPEUTICS LLC
Reel/Frame 040737/0816 →
Continuity (5)
Division 14644063 · Mar 10, 2015
Continuation In Part PCTUS2013059094 · Sep 10, 2013
Provisional Application 61699720 · Sep 11, 2012
Provisional Application 61955683 · Mar 19, 2014
Related Publication 20170143660A1 · May 25, 2017